Hi all,
I have a basic question that I’m finding it hard to obtain an answer for, my apologies if I’m a nuffy.
Ragarding development of a new drug in clinical development stage, what are the benefits and limitations of mono therapy trials and conversely combination therapy trials with already approved SOC drugs?
Hi all,I have a basic question that I’m finding it hard to...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $374.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.2¢ | 5.0¢ | $518.2K | 10.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 77 | 5147188 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 897295 | 23 |
View Market Depth
| Last trade - 13.45pm 06/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |